• Facets (new session)
• Description
• Metadata
• Settings
  • Rule: ActivityStreamsMapasEquivalentb3sb3sifpdbprdf-labelfacetshttp://dbpedia.org/resource/inference/rules/dbpedia#http://dbpedia.org/resource/inference/rules/opencyc#http://dbpedia.org/resource/inference/rules/umbel#http://dbpedia.org/resource/inference/rules/yago#http://dbpedia.org/schema/property_rules#http://www.ontologyportal.org/inference/rules/SUMO#http://www.ontologyportal.org/inference/rules/WordNet#http://www.w3.org/2002/07/owl#ldpoplwebskos-transurn:det:rdf:labelvirtrdf-labelvirtrdf-urlNone
    
  • Inverse Functional Properties: Disabled (fastest) Apply to subjects only Apply to objects only Apply to both subjects and objects
  • "Same As": Disabled (fastest) Apply to subjects only Apply to objects only Apply to both subjects and objects (recommended) Apply to subjects, objects and predicates (not recommended on big datasets) Apply to predicates only (special use cases only)

About: Rudi Pauwels     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : yago:WikicatFlemishPeople, within Data Space : dbpedia.demo.openlinksw.com associated with source document(s)

Type: Thingfoaf:Personpersondul:NaturalPersonEukaryotePersonHumanAnimalyago:WikicatBelgianScientistsanimaleukaryotespeciesschema:Personyago:WikicatLivingPeopleyago:Alumnus109786338yago:CausalAgent100007347yago:Intellectual109621545yago:LivingThing100004258yago:Object100002684yago:Organism100004475yago:Person100007846yago:PhysicalEntity100001930yago:WikicatKatholiekeUniversiteitLeuvenAlumniyago:YagoLegalActoryago:YagoLegalActorGeoyago:Scholar110557854yago:Scientist110560637yago:Whole100003553yago:WikicatFlemishPeople New Facet based on Instances of this Class

Rudi Pauwels (born 1960) is a Belgian pharmacologist and biotech entrepreneur. He studied pharmaceutical sciences at the Katholieke Universiteit Leuven (KU Leuven), Belgium. As one of the first researchers in the field of HIV, he played a key role in the fight against the AIDS pandemic by discovering several widely used anti-HIV drugs during his doctorate studies at the Rega Institute (Leuven, Belgium) and while leading biotech companies Tibotec and Virco. In 2020 he was appointed as co-chair of the Diagnostics R&D Working Group of the Access to COVID-19 Tools Accelerator.